Manara - Qatar Research Repository
10.1016_j.prp.2024.155174.pdf (1.29 MB)

Beyond genetics: Exploring the role of epigenetic alterations in breast cancer

Download (1.29 MB)
journal contribution
submitted on 2024-02-07, 04:55 and posted on 2024-02-07, 04:55 authored by Kirti S. Prabhu, Hana Q. Sadida, Shilpa Kuttikrishnan, Kulsoom Junejo, Ajaz A. Bhat, Shahab Uddin

Breast cancer remains a major global health challenge. Its rising incidence is attributed to factors such as delayed diagnosis, the complexity of its subtypes, and increasing drug resistance, all contributing to less-than-ideal patient outcomes. Central to the progression of breast cancer are epigenetic aberrations, which significantly contribute to drug resistance and the emergence of cancer stem cell traits. These include alterations in DNA methylation, histone modifications, and the expression of non-coding RNAs. Understanding these epigenetic changes is crucial for developing advanced breast cancer management strategies despite their complexity. Investigating these epigenetic modifications offers the potential for novel diagnostic markers, more accurate prognostic indicators, and the identification of reliable predictors of treatment response. This could lead to the development of new targeted therapies. However, this requires sustained, focused research efforts to navigate the challenges of understanding breast cancer carcinogenesis and its epigenetic underpinnings. A deeper understanding of epigenetic mechanisms in breast cancer can revolutionize personalized medicine. This could lead to significant improvements in patient care, including early detection, precise disease stratification, and more effective treatment options.

Other Information

Published in: Pathology - Research and Practice
See article on publisher's website:


Open Access funding provided by the Qatar National Library.



  • English



Publication Year

  • 2024

License statement

This Item is licensed under the Creative Commons Attribution 4.0 International License.

Institution affiliated with

  • Hamad Medical Corporation
  • Interim Translational Research Institute - HMC
  • Hamad General Hospital - HMC
  • Dermatology Institute - HMC
  • Sidra Medicine
  • Qatar University
  • Laboratory Animal Research Center - QU